Is it Possible to Extirpate Cardiovascular Events in Primary Aldosteronism After Surgical Treatment

Por Nishikawa, Tetsuo, Matsuzawa, Yoko, Saito, Jun, Omura, Masao
Publicado em 2010

Editorial Comment from Dr Nishikawa et al. to Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for chronic kidney dise...

Por Nishikawa, Tetsuo, Omura, Masao, Saito, Jun, Matsuzawa, Yoko, Kino, Tomoshige
Publicado em 2012

Effect of Atorvasatin on Aldosterone Production, induced by Glucose, LDL or Angiotensin II in Human Renal Mesangial Cells

Por Nishikawa, Tetsuo, Matsuzawa, Yoko, Suematsu, Sachiko, Saito, Jun, Omura, Masao, Kino, Tomoshige
Publicado em 2010

Alkalizer Administration Improves Renal Function in Hyperuricemia Associated with Obesity

Por Saito, Jun, Matsuzawa, Yoko, Ito, Hiroko, Omura, Masao, Kino, Tomoshige, Nishikawa, Tetsuo
Publicado em 2013

Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes

Por Takashi, Yuichi, Koga, Minae, Matsuzawa, Yoko, Saito, Jun, Omura, Masao, Nishikawa, Tetsuo
Publicado no J Diabetes Investig (2017)

Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration

Por Takashi, Yuichi, Koga, Minae, Matsuzawa, Yoko, Saito, Jun, Omura, Masao, Nishikawa, Tetsuo
Publicado no PLoS One (2018)

Identification of the First Japanese Family Harboring a Novel Hemoglobin Variant “Perpignan”, Which Caused Low HbA(1c) Measurement During Diabetic Follow-Up

Por Nakamura, Mami, Miyazaki, Ayako, Takubo, Takayuki, Matsuzawa, Yoko, Saito, Jun, Omura, Masao, Nishikawa, Tetsuo
Publicado em 2011

Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Atherosclerosis, β-Cell Function, and Glycemic Control in Japanese Patients with Type 2 Diabetes Mellitus...

Por Tsurutani, Yuya, Omura, Masao, Matsuzawa, Yoko, Saito, Jun, Higa, Mariko, Taniyama, Matsuo, Nishikawa, Tetsuo
Publicado no Curr Ther Res Clin Exp (2017)

The Alkalizer Citrate Reduces Serum Uric Acid Levels and Improves Renal Function in Hyperuricemic Patients Treated with the Xanthine Oxidase Inhibitor Allopurinol

Por Saito, Jun, Matsuzawa, Yoko, Ito, Hiroko, Omura, Masao, Ito, Yuzuru, Yoshimura, Koichiro, Yajima, Yuki, Kino, Tomoshige, Nishikawa, Tetsuo
Publicado em 2010

Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism

Por Tamura, Ai, Nishimoto, Koshiro, Seki, Tsugio, Matsuzawa, Yoko, Saito, Jun, Omura, Masao, Gomez-Sanchez, Celso E., Makita, Kohzoh, Matsui, Seishi, Moriya, Nobukazu, Inoue, Atsushi, Nagata, Maki, Sasano, Hironobu, Nakamura, Yasuhiro, Yamazaki, Yuto, Kabe, Yasuaki, Mukai, Kuniaki, Kosaka, Takeo, Oya, Mototsugu, Suematsu, Sachiko, Nishikawa, Tetsuo
Publicado no Mol Cell Endocrinol (2016)

Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Por Iizuka, Takashi, Iemitsu, Kotaro, Takihata, Masahiro, Takai, Masahiko, Nakajima, Shigeru, Minami, Nobuaki, Umezawa, Shinichi, Kanamori, Akira, Takeda, Hiroshi, Kawata, Takehiro, Ito, Shogo, Kikuchi, Taisuke, Amemiya, Hikaru, Kaneshiro, Mizuki, Mokubo, Atsuko, Takuma, Tetsuo, Machimura, Hideo, Tanaka, Keiji, Asakura, Taro, Kubota, Akira, Aoyagi, Sachio, Hoshino, Kazuhiko, Ishikawa, Masashi, Matsuzawa, Yoko, Obana, Mitsuo, Sasai, Nobuo, Kaneshige, Hideaki, Minagawa, Fuyuki, Saito, Tatsuya, Shinoda, Kazuaki, Miyakawa, Masaaki, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Publicado no J Clin Med Res (2016)

Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study

Por Iizuka, Takashi, Iemitsu, Kotaro, Takihata, Masahiro, Takai, Masahiko, Nakajima, Shigeru, Minami, Nobuaki, Umezawa, Shinichi, Kanamori, Akira, Takeda, Hiroshi, Kawata, Takehiro, Ito, Shogo, Kikuchi, Taisuke, Amemiya, Hikaru, Kaneshiro, Mizuki, Mokubo, Atsuko, Takuma, Tetsuo, Machimura, Hideo, Tanaka, Keiji, Asakura, Taro, Kubota, Akira, Aoyagi, Sachio, Hoshino, Kazuhiko, Ishikawa, Masashi, Matsuzawa, Yoko, Obana, Mitsuo, Sasai, Nobuo, Kaneshige, Hideaki, Minagawa, Fuyuki, Saito, Tatsuya, Shinoda, Kazuaki, Miyakawa, Masaaki, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Publicado no J Clin Med Res (2016)

Ipragliflozin Improves Glycemic Control and Decreases Body Fat in Patients With Type 2 Diabetes Mellitus

Por Kawata, Takehiro, Iizuka, Takashi, Iemitsu, Kotaro, Takihata, Masahiro, Takai, Masahiko, Nakajima, Shigeru, Minami, Nobuaki, Umezawa, Shinichi, Kanamori, Akira, Takeda, Hiroshi, Ito, Shogo, Kikuchi, Taisuke, Amemiya, Hikaru, Kaneshiro, Mizuki, Mokubo, Atsuko, Takuma, Tetsuo, Machimura, Hideo, Tanaka, Keiji, Asakura, Taro, Kubota, Akira, Aoyanagi, Sachio, Hoshino, Kazuhiko, Ishikawa, Masashi, Matsuzawa, Yoko, Obana, Mitsuo, Sasai, Nobuo, Kaneshige, Hideaki, Minagawa, Fuyuki, Saito, Tatsuya, Shinoda, Kazuaki, Miyakawa, Masaaki, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Publicado no J Clin Med Res (2017)

Effectiveness of Ipragliflozin for Reducing Hemoglobin A1c in Patients With a Shorter Type 2 Diabetes Duration: Interim Report of the ASSIGN-K Study

Por Iemitsu, Kotaro, Kawata, Takehiro, Iizuka, Takashi, Takihata, Masahiro, Takai, Masahiko, Nakajima, Shigeru, Minami, Nobuaki, Umezawa, Shinichi, Kanamori, Akira, Takeda, Hiroshi, Ito, Shogo, Kikuchi, Taisuke, Amemiya, Hikaru, Kaneshiro, Mizuki, Mokubo, Atsuko, Takuma, Tetsuo, Machimura, Hideo, Tanaka, Keiji, Asakura, Taro, Kubota, Akira, Aoyanagi, Sachio, Hoshino, Kazuhiko, Ishikawa, Masashi, Matsuzawa, Yoko, Obana, Mitsuo, Sasai, Nobuo, Kaneshige, Hideaki, Minagawa, Fuyuki, Saito, Tatsuya, Shinoda, Kazuaki, Miyakawa, Masaaki, Tanaka, Yasushi, Terauchi, Yasuo, Matsuba, Ikuro
Publicado no J Clin Med Res (2017)